Johnson & Johnson is set to report earnings before the bell Wednesday, with analysts expecting revenue and profit growth from ...
Staying ahead of the competition is critical in every sector, particularly in the dynamic healthcare space, where a single ...
Intra-Cellular Therapies makes Caplyta, a once-daily pill for adults with schizophrenia and bipolar-related depression ...
Johnson & Johnson (NYSE: JNJ) stock is up 1.8% in the five days after the company announced its $14.6 billion acquisition of ...
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Johnson & Johnson has underperformed its large-cap healthcare peers and the S&P 500, with an -8% decline over the past year.
Johnson & Johnson (NYSE:JNJ) has had a rough three months with its share price down 11%. However, stock prices ...
House Speaker Mike Johnson said President-elect Trump’s mass deportation plan to restore safety and security to the country ...